1. Home
  2. OPOF vs ADVM Comparison

OPOF vs ADVM Comparison

Compare OPOF & ADVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OPOF
  • ADVM
  • Stock Information
  • Founded
  • OPOF 1922
  • ADVM 2006
  • Country
  • OPOF United States
  • ADVM United States
  • Employees
  • OPOF N/A
  • ADVM N/A
  • Industry
  • OPOF Major Banks
  • ADVM Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • OPOF Finance
  • ADVM Health Care
  • Exchange
  • OPOF Nasdaq
  • ADVM Nasdaq
  • Market Cap
  • OPOF 103.7M
  • ADVM 119.6M
  • IPO Year
  • OPOF N/A
  • ADVM 2014
  • Fundamental
  • Price
  • OPOF $21.32
  • ADVM $6.04
  • Analyst Decision
  • OPOF
  • ADVM Strong Buy
  • Analyst Count
  • OPOF 0
  • ADVM 6
  • Target Price
  • OPOF N/A
  • ADVM $27.83
  • AVG Volume (30 Days)
  • OPOF 20.3K
  • ADVM 245.9K
  • Earning Date
  • OPOF 10-24-2024
  • ADVM 11-04-2024
  • Dividend Yield
  • OPOF 2.59%
  • ADVM N/A
  • EPS Growth
  • OPOF N/A
  • ADVM N/A
  • EPS
  • OPOF 1.60
  • ADVM N/A
  • Revenue
  • OPOF $59,503,000.00
  • ADVM $1,000,000.00
  • Revenue This Year
  • OPOF N/A
  • ADVM N/A
  • Revenue Next Year
  • OPOF N/A
  • ADVM $1,294.35
  • P/E Ratio
  • OPOF $12.95
  • ADVM N/A
  • Revenue Growth
  • OPOF N/A
  • ADVM N/A
  • 52 Week Low
  • OPOF $13.49
  • ADVM $5.69
  • 52 Week High
  • OPOF $21.89
  • ADVM $29.70
  • Technical
  • Relative Strength Index (RSI)
  • OPOF 63.59
  • ADVM 31.12
  • Support Level
  • OPOF $20.30
  • ADVM $6.81
  • Resistance Level
  • OPOF $21.89
  • ADVM $7.73
  • Average True Range (ATR)
  • OPOF 0.66
  • ADVM 0.46
  • MACD
  • OPOF -0.03
  • ADVM -0.22
  • Stochastic Oscillator
  • OPOF 51.10
  • ADVM 14.06

About OPOF Old Point Financial Corporation

Old Point Financial Corp functions in the financial services domain in the United States. As the holding company of The Bank and Trust, it is a nationally chartered trust and wealth management service, provider. Its suite of services includes commercial banking solutions such as loan, deposit and cash management, which are rendered through a chain of branches throughout the country. It operates through segments such as Bank, Wealth and Company.

About ADVM Adverum Biotechnologies Inc.

Adverum Biotechnologies Inc is a U.S.-based clinical-stage gene therapy company. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. The company primarily generates revenue through license, research and collaboration arrangements with its strategic partners. Its lead product candidate is ADVM-022 which is a single, in-office intravitreal (IVT) injection gene therapy designed to deliver long-term durable levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with frequent anti-vascular endothelial growth factor (VEGF) injections. It has one segment developing and commercializing gene therapeutics.

Share on Social Networks: